GABAPENTIN
Generic: GABAPENTIN
GABAPENTIN is FDA application ANDA213603, sponsored by ZHEJIANG YONGTAI. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine
CGMP Deviations
Cross Contamination
Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off -
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaki
Product mixup: one foreign tablet found in product.
Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term s
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaki